BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, March 2, 2025
See today's BioWorld MedTech
Home
» Med-tech deal value up more than 100% YOY, monthly M&As at 2-year low
To read the full story,
subscribe
or
sign in
.
Med-tech deals June 2023
Med-tech deal value up more than 100% YOY, monthly M&As at 2-year low
July 14, 2023
By
Amanda Lanier
No Comments
Year over year, med-tech deal values were up more than 100% in June, while the value of mergers and acquisitions decreased by nearly 100%.
BioWorld MedTech
Analysis and data insight
Deals and M&A